deltatrials
Unknown PHASE1 INTERVENTIONAL 1-arm NCT02497599

Intraoperative Dual-modality Imaging in Renal Cell Carcinoma

A Phase 1 Study to Evaluate the Safety and Feasibility of Intraoperative Detection of Clear Cell Renal Cell Carcinoma Using Indium-111-DOTA-girentuximab-IRDye800CW

Sponsor: Radboud University Medical Center

Conditions Carcinoma, Renal Cell
Interventions Indium-111-DOTA-Girentuximab-IRDye800CW Intraoperative dual-modality imaging SPECT/CT
Updated 10 times since 2017 Last updated: Sep 23, 2021 Started: Jun 30, 2015 Primary completion: Dec 31, 2021 Completion: Apr 30, 2022
This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

This PHASE1 trial investigates Carcinoma, Renal Cell and is currently ongoing. Radboud University Medical Center leads this study, which shows 10 recorded versions since 2015 — indicating substantial longitudinal coverage. As an oncology study, it adds to the longitudinal record of treatment development for this indication.

Status Flow

~Jan 2017 – ~Jun 2018 · 17 months · monthly snapshotRecruiting~Jun 2018 – ~Oct 2018 · 4 months · monthly snapshotRecruiting~Oct 2018 – ~Sep 2020 · 23 months · monthly snapshotActive Not Recruiting~Sep 2020 – ~Jan 2021 · 4 months · monthly snapshotUnknown Status~Jan 2021 – ~Oct 2021 · 9 months · monthly snapshotUnknown Status~Oct 2021 – ~Mar 2022 · 5 months · monthly snapshotRecruiting~Mar 2022 – ~Apr 2023 · 13 months · monthly snapshotRecruiting~Apr 2023 – ~Jul 2024 · 15 months · monthly snapshotUnknown Status~Jul 2024 – ~Sep 2024 · 2 months · monthly snapshotUnknown~Sep 2024 – present · 22 months · monthly snapshotUnknown

Change History

10 versions recorded

  1. Sep 2024 — Present [monthly]

    Unknown PHASE1

  2. Jul 2024 — Sep 2024 [monthly]

    Unknown PHASE1

    Status: Unknown Status → Unknown

  3. Apr 2023 — Jul 2024 [monthly]

    Unknown Status PHASE1

    Status: Recruiting → Unknown Status

  4. Mar 2022 — Apr 2023 [monthly]

    Recruiting PHASE1

  5. Oct 2021 — Mar 2022 [monthly]

    Recruiting PHASE1

    Status: Unknown Status → Recruiting

▶ Show 5 earlier versions

  1. Jan 2021 — Oct 2021 [monthly]

    Unknown Status PHASE1

  2. Sep 2020 — Jan 2021 [monthly]

    Unknown Status PHASE1

    Status: Active Not Recruiting → Unknown Status

  3. Oct 2018 — Sep 2020 [monthly]

    Active Not Recruiting PHASE1

    Status: Recruiting → Active Not Recruiting

  4. Jun 2018 — Oct 2018 [monthly]

    Recruiting PHASE1

  5. Jan 2017 — Jun 2018 [monthly]

    Recruiting PHASE1

    First recorded

Jun 2015

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:
  • Radboud University Medical Center
Data source: Radboud University Medical Center

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations